The Journal of Bone and Joint Surgery (American) 86:783-786 (2004)
© 2004 The Journal of Bone and Joint Surgery, Inc.
Prospective Matched-Pair Analysis of Hydroxyapatite-Coated and Uncoated Femoral Stems in Total Hip Arthroplasty
A Concise Follow-up of a Previous Report*
Javad Parvizi, MD, FRCS1,
Peter F. Sharkey, MD1,
William J. Hozack, MD1,
Fabio Orzoco, MD1,
Gina A. Bissett1 and
Richard H. Rothman, MD, PhD1
1 Department of Orthopedic Surgery, Rothman Institute, 925 Chestnut Street,
Philadelphia, PA 19107. E-mail address for R.H. Rothman:
rhrothman{at}aol.com
Investigation performed at the Department of Orthopedic Surgery,
Rothman Institute, Philadelphia, Pennsylvania
The authors did not receive grants or outside funding in support of their
research or preparation of this manuscript. They did not receive payments or
other benefits or a commitment or agreement to provide such benefits from a
commercial entity. No commercial entity paid or directed, or agreed to pay or
direct, any benefits to any research fund, foundation, educational
institution, or other charitable or nonprofit organization with which the
authors are affiliated or associated.
* Original Publication
Rothman RH, Hozack WJ, Ranawat A, Moriarity L. Hydroxyapatite-coated
femoral stems. A matched-pair analysis of coated and uncoated implants. J
Bone and Joint Surg Am. 1996;78:319-24.
A commentary is available with the electronic versions of this article,
on our web site (www.jbjs.org) and on our quarterly CD-ROM (call our
subscription department, at 781-449-9780, to order the CD-ROM).
This prospective study was performed to examine the results of total hip
arthroplasty with a tapered uncemented femoral component with and without
hydroxyapatite coating in a matched-pair group of patients. Since our original
publication in 1996, no femoral component was revised in either group. After a
mean clinical and radiographic follow-up of 9.8 years, all femoral components
were stable, with no evidence of progressive radiolucency or osteolysis. Ten
acetabular components were revised because of aseptic loosening and wear. Our
study demonstrated no clinical or radiographic advantage, during the first
decade after implantation, to the use of hydroxyapatite on this design of
femoral component in primary total hip arthroplasty.
Level of Evidence: Therapeutic study, Level II-1
(prospective cohort study). See Instructions to Authors for a complete
description of levels of evidence.

CiteULike Connotea Del.icio.us Technorati What's this?
|